Search Results - "Dickson, Dorothy M."

Network analysis of patterns and relevance of enteric pathogen co-infections among infants in a diarrhea-endemic setting by Colgate, E Ross, Klopfer, Connor, Dickson, Dorothy M, Lee, Benjamin, Wargo, Matthew J, Alam, Ashraful, Kirkpatrick, Beth D, Hébert-Dufresne, Laurent

“…Despite significant progress in recent decades toward ameliorating the excess burden of diarrheal disease globally, childhood diarrhea remains a leading cause…”
Get full text

The "Performance of Rotavirus and Oral Polio Vaccines in Developing Countries" (PROVIDE) study: description of methods of an interventional study designed to explore complex biologic problems by Kirkpatrick, Beth D, Colgate, E Ross, Mychaleckyj, Josyf C, Haque, Rashidul, Dickson, Dorothy M, Carmolli, Marya P, Nayak, Uma, Taniuchi, Mami, Naylor, Caitlin, Qadri, Firdausi, Ma, Jennie Z, Alam, Masud, Walsh, Mary Claire, Diehl, Sean A, Petri, Jr, William A

“…Oral vaccines appear less effective in children in the developing world. Proposed biologic reasons include concurrent enteric infections, malnutrition, breast…”
Get full text

Immunotranscriptomic profiling the acute and clearance phases of a human challenge dengue virus serotype 2 infection model by Hanley, John P., Tu, Huy A., Dragon, Julie A., Dickson, Dorothy M., Rio-Guerra, Roxana del, Tighe, Scott W., Eckstrom, Korin M., Selig, Nicholas, Scarpino, Samuel V., Whitehead, Stephen S., Durbin, Anna P., Pierce, Kristen K., Kirkpatrick, Beth D., Rizzo, Donna M., Frietze, Seth, Diehl, Sean A.

“…About 20–25% of dengue virus (DENV) infections become symptomatic ranging from self-limiting fever to shock. Immune gene expression changes during progression…”
Get full text

In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination by Whitehead, Stephen S, Durbin, Anna P, Pierce, Kristen K, Elwood, Dan, McElvany, Benjamin D, Fraser, Ellen A, Carmolli, Marya P, Tibery, Cecilia M, Hynes, Noreen A, Jo, Matthew, Lovchik, Janece M, Larsson, Catherine J, Doty, Elena A, Dickson, Dorothy M, Luke, Catherine J, Subbarao, Kanta, Diehl, Sean A, Kirkpatrick, Beth D

“…Infection caused by the four serotypes of dengue virus (DENV-1-4) is a leading cause of mosquito-borne disease. Clinically-severe dengue disease is more common…”
Get full text

Oral rotavirus vaccine shedding as a marker of mucosal immunity by Lee, Benjamin, Kader, Md Abdul, Colgate, E. Ross, Carmolli, Marya, Dickson, Dorothy M., Diehl, Sean A., Alam, Masud, Afreen, Sajia, Mychaleckyj, Josyf C., Nayak, Uma, Petri, William A., Haque, Rashidul, Kirkpatrick, Beth D.

“…Group A rotaviruses (RVA) remain a leading cause of pediatric diarrhea worldwide, in part due to underperformance of currently approved live-attenuated, oral…”
Get full text

Infant Non-Secretor Histoblood Group Antigen Phenotype Reduces Susceptibility to Both Symptomatic and Asymptomatic Rotavirus Infection by Lee, Benjamin, Kader, Md Abdul, Alam, Masud, Dickson, Dorothy M, Harvey, Patrick, Colgate, E Ross, Taniuchi, Mami, Petri, Jr, William A, Haque, Rashidul, Kirkpatrick, Beth D

“…The infant non-secretor histoblood group antigen phenotype is associated with reduced risk of symptomatic rotavirus diarrhea, one of the leading global causes…”
Get full text

Histo–Blood Group Antigen Phenotype Determines Susceptibility to Genotype-Specific Rotavirus Infections and Impacts Measures of Rotavirus Vaccine Efficacy by Lee, Benjamin, Dickson, Dorothy M, deCamp, Allan C, Ross Colgate, E, Diehl, Sean A, Uddin, Muhammad Ikhtear, Sharmin, Salma, Islam, Shahidul, Bhuiyan, Taufiqur Rahman, Alam, Masud, Nayak, Uma, Mychaleckyj, Josyf C, Taniuchi, Mami, Petri, William A, Haque, Rashidul, Qadri, Firdausi, Kirkpatrick, Beth D

“…Abstract Background Lewis and secretor histo–blood group antigens (HBGAs) have been associated with decreased susceptibility to P[8] genotype rotavirus (RV)…”
Get full text

Safety and durable immunogenicity of the TV005 tetravalent dengue vaccine, across serotypes and age groups, in dengue-endemic Bangladesh: a randomised, controlled trial by Walsh, Mary-Claire R, Alam, Mohammed Shafiul, Pierce, Kristen K, Carmolli, Marya, Alam, Masud, Dickson, Dorothy M, Bak, Dan M, Afreen, Sajia, Nazib, Forida, Golam, Kibria, Qadri, Firdausi, Diehl, Sean A, Durbin, Anna P, Whitehead, Stephen S, Haque, Rashidul, Kirkpatrick, Beth D

“…Morbidity and mortality from dengue virus (DENV) is rapidly growing in the large populations of south Asia. Few formal evaluations of candidate dengue vaccine…”
Get full text

TV005 dengue vaccine protects against dengue serotypes 2 and 3 in two controlled human infection studies by Pierce, Kristen K, Durbin, Anna P, Walsh, Mary-Claire R, Carmolli, Marya, Sabundayo, Beulah P, Dickson, Dorothy M, Diehl, Sean A, Whitehead, Stephen S, Kirkpatrick, Beth D

“…BACKGROUNDDisease due to dengue viruses is a growing global health threat, causing 100-400 million cases annually. An ideal dengue vaccine should demonstrate…”
Get full text

Maternal Secretor Status Affects Oral Rotavirus Vaccine Response in Breastfed Infants in Bangladesh by Williams, Frank B, Kader, Abdul, Colgate, E Ross, Dickson, Dorothy M, Carmolli, Marya, Uddin, Muhammad Ikhtear, Sharmin, Salma, Islam, Shahidul, Bhuiyan, Taufiqur Rahman, Alam, Masud, Nayak, Uma, Mychaleckyj, Josyf C, Petri, William A, Haque, Rashidul, Qadri, Firdausi, Kirkpatrick, Beth D, Lee, Benjamin

“…Abstract Secretor status controls mucosal histo–blood group antigen expression and is associated with susceptibility to rotavirus (RV) diarrhea, with…”
Get full text

Impact of enterovirus and other enteric pathogens on oral polio and rotavirus vaccine performance in Bangladeshi infants by Taniuchi, Mami, Platts-Mills, James A, Begum, Sharmin, Uddin, Md Jashim, Sobuz, Shihab U, Liu, Jie, Kirkpatrick, Beth D, Colgate, E. Ross, Carmolli, Marya P, Dickson, Dorothy M, Nayak, Uma, Haque, Rashidul, Petri, William A, Houpt, Eric R

“…Highlights • Oral vaccines exhibit poor performance in low-income settings. • Enterovirus and Campylobacter carriage are associated with lower OPV…”
Get full text

Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized placebo-controlled trial by Crothers, Jessica W., Ross Colgate, Elizabeth, Cowan, Kelly J., Dickson, Dorothy M., Walsh, MaryClaire, Carmolli, Marya, Wright, Peter F., Norton, Elizabeth B., Kirkpatrick, Beth D.

“…Eradication of poliomyelitis globally is constrained by fecal shedding of live polioviruses, both wild-type and vaccine-derived strains, into the environment…”
Get full text

Delayed Dosing of Oral Rotavirus Vaccine Demonstrates Decreased Risk of Rotavirus Gastroenteritis Associated With Serum Zinc: A Randomized Controlled Trial by Colgate, E. Ross, Haque, Rashidul, Dickson, Dorothy M., Carmolli, Marya P., Mychaleckyj, Josyf C., Nayak, Uma, Qadri, Firdausi, Alam, Masud, Walsh, Mary Claire, Diehl, Sean A., Zaman, K., Petri, William A., Kirkpatrick, Beth D.

“…Background. Rotavirus is the world's leading cause of childhood diarrheal death. Despite successes, oral rotavirus vaccines are less effective in developing…”
Get full text

Rotavirus-Specific Immunoglobulin A Responses Are Impaired and Serve as a Suboptimal Correlate of Protection Among Infants in Bangladesh by Lee, Benjamin, Carmolli, Marya, Dickson, Dorothy M, Colgate, E Ross, Diehl, Sean A, Uddin, Muhammad Ikhtear, Islam, Shahidul, Hossain, Motaher, Rafique, Tanzeem Ahmed, Bhuiyan, Taufiqur Rahman, Alam, Masud, Nayak, Uma, Mychaleckyj, Josyf C, McNeal, Monica M, Petri, William A, Qadri, Firdausi, Haque, Rashidul, Kirkpatrick, Beth D

“…Abstract Background Rotavirus (RV)-specific immunoglobulin A (IgA) responses following oral RV vaccination are impaired in low-income countries, where the…”
Get full text

Corrigendum to “Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized active-controlled trial” [Vaccine 40(19) (2022) 2705–2713] by Crothers, Jessica W., Ross Colgate, Elizabeth, Cowan, Kelly J., Dickson, Dorothy M., Walsh, MaryClaire, Carmolli, Marya, Wright, Peter F., Norton, Elizabeth B., Kirkpatrick, Beth D.

Get full text

The effect of increased inoculum on oral rotavirus vaccine take among infants in Dhaka, Bangladesh: A double-blind, parallel group, randomized, controlled trial by Lee, Benjamin, Dickson, Dorothy M., Alam, Masud, Afreen, Sajia, Kader, Abdul, Afrin, Faria, Ferdousi, Tania, Damon, Christina F., Gullickson, Soyeon K., McNeal, Monica M., Bak, Daniel M., Tolba, Mona, Carmolli, Marya P., Taniuchi, Mami, Haque, Rashidul, Kirkpatrick, Beth D.

“…•Oral rotavirus vaccines underperform in low-income countries.•A double vaccine dose did not improve immune response among infants in Bangladesh.•Infants with…”
Get full text

Maternal Breast Milk Secretor Phenotype Does Not Affect Infant Susceptibility to Rotavirus Diarrhea by Williams, Frank B, Kader, Md Abdul, Dickson, Dorothy M, Colgate, E Ross, Alam, Masud, Haque, Rashidul, Petri, William A, Kirkpatrick, Beth D, Lee, Benjamin

“…Abstract Breast milk secretor status is associated with antibody seroconversion to oral rotavirus vaccination. Here, we were unable to detect a similar impact…”
Get full text

Plasma VP8∗-Binding Antibodies in Rotavirus Infection and Oral Vaccination in Young Bangladeshi Children by Lee, Benjamin, Colgate, E Ross, Carmolli, Marya, Dickson, Dorothy M, Gullickson, Soyeon, Diehl, Sean A, Ara, Rifat, Alam, Masud, Kibria, Golam, Abdul Kader, Md, Afreen, Sajia, Ferdous, Tahsin, Haque, Rashidul, Kirkpatrick, Beth D

“…Abstract Background Despite the availability and success of live-attenuated oral vaccines, rotavirus (RV) remains the leading cause of pediatric…”
Get full text

Histo–Blood Group Antigen Phenotype Determines Susceptibility to Genotype-Specific Rotavirus Infections and Impacts Measures of Rotavirus Vaccine Efficacy by Lee, Benjamin, Dickson, Dorothy M, deCamp, Allan C, Ross Colgate, E, Diehl, Sean A, Uddin, Muhammad Ikhtear, Sharmin, Salma, Islam, Shahidul, Bhuiyan, Taufiqur Rahman, Alam, Masud, Nayak, Uma, Mychaleckyj, Josyf C, Taniuchi, Mami, Petri, William A, Haque, Rashidul, Qadri, Firdausi, Kirkpatrick, Beth D

Get full text

TV005 dengue vaccine protects against dengue serotypes 2 and 3 in two controlled human infection studies by Pierce, Kristen K, Durbin, Anna R, Walsh, Mary-Claire R, Carmolli, Marya, Sabundayo, Beulah R, Dickson, Dorothy M, Diehl, Sean A, Whitehead, Stephen S, Kirkpatrick, Beth D

“…BACKGROUND. Disease dueto dengue viruses is a growing global health threat, causing 100-400 million cases annually. An ideal dengue vaccine should demonstrate…”
Get full text